Home LiteratureArticle Details
PMID: 1836353 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

A synthetic peptide of the N-terminus of actin interacts with myosin.

Biochemistry ·Vol. 30 ·No. 50 ·1991-12-17 ·Pages 11676-82

Van Eyk JE, Hodges RS

Abstract

Research reported from numerous laboratories suggested that the N-terminal region of actin contained one of the binding sites between actin and myosin. A synthetic peptide corresponding to residues 1-28 of skeletal actin was prepared by solid-phase peptide methodology. The formation of a complex between this peptide and myosin subfragment 1 (S1) was demonstrated by high-performance size-exclusion chromatography (pH 6.8). The actin peptide precipitated S1 at higher pH (7.4-8.2) but remained soluble when bound to heavy meromyosin (HMM) or S1 in the presence of F-actin. The actin peptide 1-28 bound to S1 and HMM and activated the ATPase activity in a manner similar to that of F-actin. These results demonstrate that the N-terminal region of actin, residues 1-28, contains a biologically important binding site for myosin.

MeSH Terms
Actins/chemical synthesis,metabolism Adenosine Triphosphatases/metabolism Amino Acid Sequence Animals Binding Sites Chromatography, Gel Electrophoresis, Polyacrylamide Gel Molecular Sequence Data Muscles/metabolism Myosins/metabolism Rabbits
Chemicals
Actins Adenosine Triphosphatases Myosins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Van Eyk J E
Department of Biochemistry, University of Alberta, Edmonton, Canada.
Hodges R S
Article Info
Journal
Biochemistry
Abbr.
Biochemistry
ISSN
0006-2960
Published
1991-12-17
Pages
11676-82
Language
English
Region
United States
NLM ID
0370623
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]